CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$54,620
-5.7%
36,4130.0%0.00%
Q2 2023$57,897
+28.3%
36,413
-42.1%
0.00%
Q1 2023$45,135
+23.8%
62,9140.0%0.00%
Q4 2022$36,459
-39.2%
62,9140.0%0.00%
Q3 2022$60,000
-76.7%
62,914
-67.9%
0.00%
Q1 2022$257,000
-32.5%
195,885
-9.4%
0.00%
Q4 2021$381,000
-18.9%
216,1390.0%0.00%
Q3 2021$470,000
-78.2%
216,139
-65.0%
0.00%
-100.0%
Q2 2021$2,160,000
-64.2%
616,913
+0.9%
0.00%
-50.0%
Q1 2021$6,026,000
-6.3%
611,108
+3.0%
0.00%
-33.3%
Q4 2020$6,432,000
+9.0%
593,298
+3.6%
0.00%0.0%
Q3 2020$5,899,000
-37.6%
572,682
+26.6%
0.00%
-40.0%
Q2 2020$9,447,000
+151.0%
452,396
+17.5%
0.01%
+150.0%
Q1 2020$3,763,000
-0.8%
385,156
+16.9%
0.00%0.0%
Q4 2019$3,795,000
+116.5%
329,375
+2.4%
0.00%
+100.0%
Q3 2019$1,753,000
+13.4%
321,599
+147.5%
0.00%0.0%
Q2 2019$1,546,000
+133.9%
129,942
+3.0%
0.00%
Q1 2019$661,000
+84.1%
126,132
+11.0%
0.00%
Q4 2018$359,000
-47.8%
113,6770.0%0.00%
Q3 2018$688,000
+14.1%
113,6770.0%0.00%
Q2 2018$603,000
+683.1%
113,677
+303.0%
0.00%
Q1 2017$77,000
-6.1%
28,2090.0%0.00%
Q4 2016$82,000
-29.3%
28,2090.0%0.00%
Q3 2016$116,000
+28.9%
28,2090.0%0.00%
Q2 2016$90,00028,2090.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,112,355$40,178,00034.81%
Versant Venture Management, LLC 7,068,233$69,056,636,00018.94%
ACUTA CAPITAL PARTNERS, LLC 1,704,500$16,653,0008.07%
Soleus Capital Management, L.P. 313,900$3,067,0003.57%
Ghost Tree Capital, LLC 1,305,500$12,755,0003.38%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,690,0002.97%
RTW INVESTMENTS, LP 6,631,627$64,791,0002.79%
VR Adviser, LLC 994,381$9,715,0002.63%
Avoro Capital Advisors LLC 7,150,000$69,856,0002.36%
RA Capital Management 7,272,714$71,054,0002.24%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders